Drug recall · March 6, 2013
buPROPion Hydrochloride Extended - Release Tablets recall
Why: Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217
- Lots / codes
Lot CB1D05A,
- Quantity
- 14,856 bottles
- Company
- Actavis Pharmaceuticals, Morristown, NJ
- Distribution
- Nationwide
- Initiated
- January 4, 2013 · Voluntary: Firm initiated
- Classified
- February 27, 2013
- Reported
- March 6, 2013
- Ended
- January 13, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.